{"donor_id":"CPCG0251","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"52","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 13.41","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0255","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"72","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.90","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0256","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"63","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.32","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0258","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"49","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.13","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0259","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"55","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 11.65","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0260","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"65","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.59","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0262","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"62","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.70","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0263","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"66","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 13.90","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0265","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"63","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 9.34","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0266","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"66","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 1.74","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0267","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"44","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 17.10","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0268","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"59","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 12.35","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0269","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"68","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 13.21","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0324","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"64","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 12.10","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0331","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"69","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 11.08","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0334","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"53","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.41","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0336","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"60","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 9.08","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0339","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"57","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 14.29","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0340","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"61","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.41","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0341","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"56","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 11.30","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0342","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"52","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.30","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0344","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"60","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.50","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0345","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"60","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.60","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0346","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"59","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.50","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0348","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"57","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.22","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0350","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"53","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 39.47","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0352","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"55","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 9.10","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0353","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"65","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 9.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0354","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"61","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.70","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0355","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"55","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.70","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0356","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"51","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 8.49","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0357","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"59","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 3.11","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0358","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"68","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.88","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0360","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"66","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 14.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0361","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"70","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.60","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0362","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"57","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 8.77","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0363","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"56","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.27","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0364","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"63","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 8.11","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0365","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"71","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.23","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0366","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"60","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 15.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0368","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"63","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.39","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0369","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"63","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.18","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0371","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"60","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.52","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0372","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"60","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0373","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"59","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.90","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0374","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"63","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.70","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0375","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"70","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 7.01","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0378","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"69","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 8.70","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0379","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"68","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 14.60","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0380","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"58","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.29","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0381","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"64","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.76","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0387","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"67","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 4.52","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0388","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"54","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 2.50","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0391","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"60","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.30","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0392","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":"alive","disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"61","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 19.50","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0401","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"58","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 3.60","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0404","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"56","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 3.60","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0407","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"57","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 11.50","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0409","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"59","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.30","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0410","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"61","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.00","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0411","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"45","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1C","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 10.55","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0412","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"58","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 3.36","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0413","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"59","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T2A","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 6.89","_project_id":"PRAD-CA"}
{"donor_id":"CPCG0414","donor_sex":"male","donor_region_of_residence":null,"donor_vital_status":null,"disease_status_last_followup":null,"donor_relapse_type":null,"donor_age_at_diagnosis":null,"donor_age_at_enrollment":"43","donor_age_at_last_followup":null,"donor_relapse_interval":null,"donor_diagnosis_icd10":null,"donor_tumour_staging_system_at_diagnosis":"TMN","donor_tumour_stage_at_diagnosis":"T1B","donor_tumour_stage_at_diagnosis_supplemental":null,"donor_survival_time":null,"donor_interval_of_last_followup":null,"donor_notes":"PreTreatment PSA : 5.40","_project_id":"PRAD-CA"}
